News
Cantor Fitzgerald Reiterates Overweight on R1 RCM, Maintains $20 Price Target
10 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Keybanc Downgrades R1 RCM to Sector Weight
10 Apr 24
News, Downgrades, Analyst Ratings
The Latest Analyst Ratings For R1 RCM
5 Apr 24
Analyst Ratings
Guggenheim Maintains Buy on R1 RCM, Lowers Price Target to $15
5 Apr 24
News, Price Target, Analyst Ratings
Truist Securities Maintains Hold on R1 RCM, Maintains $16 Price Target
1 Apr 24
News, Price Target, Analyst Ratings
Morgan Stanley Reiterates Overweight on R1 RCM, Maintains $17 Price Target
26 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Analyst Scoreboard: 12 Ratings For R1 RCM
20 Mar 24
Analyst Ratings
Canaccord Genuity Maintains Buy on R1 RCM, Lowers Price Target to $16
20 Mar 24
News, Price Target, Analyst Ratings
Citigroup Upgrades R1 RCM to Buy, Announces $16 Price Target
20 Mar 24
News, Upgrades, Price Target, Analyst Ratings
R1 RCM Forms Special Committee To Evaluate Strategic Alternatives
11 Mar 24
News, Management
Alphabet, Dover And 2 Other Stocks Insiders Are Selling
11 Mar 24
News, Short Ideas, Small Cap, Insider Trades, Pre-Market Outlook, Markets, Trading Ideas
Cantor Fitzgerald Reiterates Overweight on R1 RCM, Maintains $20 Price Target
5 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Truist Securities Downgrades R1 RCM to Hold, Announces $16 Price Target
5 Mar 24
News, Downgrades, Price Target, Analyst Ratings
Citigroup Maintains Buy on R1 RCM, Raises Price Target to $16
1 Mar 24
News, Price Target, Analyst Ratings
Keybanc Maintains Overweight on R1 RCM, Raises Price Target to $17
29 Feb 24
News, Price Target, Analyst Ratings
Assessing R1 RCM: Insights From 10 Financial Analysts
28 Feb 24
Analyst Ratings
Barclays Downgrades R1 RCM to Equal-Weight, Maintains Price Target to $14
28 Feb 24
News, Downgrades, Price Target, Analyst Ratings
Evercore ISI Group Downgrades R1 RCM to In-Line, Raises Price Target to $16
28 Feb 24
News, Downgrades, Price Target, Analyst Ratings
Healthcare IT-R1 RCM's Shareholder Says $13.75/Share Deal Offer Significantly Undervalues The Company
27 Feb 24
M&A, News, Health Care, Movers, Tech, Trading Ideas, General
R1 RCM Expects FY24 Revenue of $2.625B-$2.675B Vs $2.69B Est
27 Feb 24
News, Guidance
Press releases
R1 RCM to Present at the 2024 Bank of America Securities Health Care Conference
30 Apr 24
News, Press Releases
R1 RCM to Release First Quarter 2024 Results on May 8, 2024
1 Apr 24
News, Press Releases
R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report
27 Mar 24
Press Releases
R1 RCM Inc. (RCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
1 Mar 24
Press Releases
R1 RCM Inc. (RCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
28 Feb 24
Press Releases
Coliseum Capital Issues Open Letter to Board of R1 RCM on Offer by New Mountain to Acquire the Company for $13.75 Per Share
26 Feb 24
Press Releases
R1 RCM to Present at Upcoming Investor Conferences
16 Feb 24
News, Press Releases